Posts Tagged :

Clinical Outcomes

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy

    This poster evaluates existing oral oncology medication waste events among patients filling at a HSSP.  

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

This poster evaluates the clinical and quality outcomes of a bleeding disorder program at a health system HSSP.

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation 216 115 Shields Health Solutions

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation

This poster aims to establish goals for a dashboard displaying medication adherence by disease state and PDC thresholds through a comprehensive literature review, validating the existing targets.

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients

This poster explores the impact of a Health System Specialty Pharmacy care model paired with a pharmacist-led CDTM program on CF patient outcomes.

Market Trends to Watch for Health Systems and Their Specialty Pharmacies 204 115 Shields Health Solutions

Market Trends to Watch for Health Systems and Their Specialty Pharmacies

This article was published in MedCity News on November 18, 2024. The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for…

Impact of an Integrated Health System Specialty Pharmacy Liaison-Managed Care Model within an Uncontrolled Diabetes Population 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy Liaison-Managed Care Model within an Uncontrolled Diabetes Population

This poster explores the impact of the pharmacy liaison-managed care model at CHRISTUS Health System on HbA1c reduction and medication adherence for patients living with diabetes with baseline A1C>9.

Hep-C Outcomes 2023 216 115 Shields Health Solutions

Hep-C Outcomes 2023

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.